A detailed history of Ilmarinen Mutual Pension Insurance CO transactions in Amgen Inc stock. As of the latest transaction made, Ilmarinen Mutual Pension Insurance CO holds 56,500 shares of AMGN stock, worth $15.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
56,500
Previous 56,500 -0.0%
Holding current value
$15.4 Million
Previous $17.7 Million 3.13%
% of portfolio
0.2%
Previous 0.21%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$255.7 - $288.46 $639,250 - $721,150
-2,500 Reduced 4.24%
56,500 $16.3 Million
Q1 2023

May 17, 2023

BUY
$225.79 - $275.2 $2.26 Million - $2.75 Million
10,000 Added 20.41%
59,000 $14.3 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $2.98 Million - $3.78 Million
-13,000 Reduced 20.97%
49,000 $12.9 Million
Q2 2021

Oct 29, 2021

BUY
$233.58 - $259.14 $14.5 Million - $16.1 Million
62,000 New
62,000 $15.1 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $14.5 Million - $16.1 Million
-62,000 Closed
0 $0
Q1 2021

Oct 29, 2021

BUY
$221.91 - $258.6 $13.8 Million - $16 Million
62,000 New
62,000 $15.4 Million
Q1 2021

Apr 23, 2021

SELL
$221.91 - $258.6 $13.8 Million - $16 Million
-62,000 Closed
0 $0
Q4 2020

Oct 29, 2021

BUY
$216.38 - $257.67 $13.4 Million - $16 Million
62,000 New
62,000 $14.3 Million
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $19.3 Million - $22.9 Million
-89,000 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $4.35 Million - $5.59 Million
23,000 Added 34.85%
89,000 $21.5 Million
Q3 2019

Nov 27, 2019

BUY
$174.11 - $208.62 $11.5 Million - $13.8 Million
66,000 New
66,000 $12.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ilmarinen Mutual Pension Insurance CO Portfolio

Follow Ilmarinen Mutual Pension Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ilmarinen Mutual Pension Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Ilmarinen Mutual Pension Insurance CO with notifications on news.